BackSensei Biotherapeutics Overview

Sensei Biotherapeutics Current Cash

Track Sensei Biotherapeutics's current cash ($150M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$152.32M
1442.22% YoYΔ $142.45M vs prior year quarter

Peer average

Loading

Sensei Biotherapeutics Current Cash History

Loading

Sensei Biotherapeutics vs. peers: Current Cash Comparison

Loading

Sensei Biotherapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sensei Biotherapeutics (SNSE) FAQ

The latest current cash for SNSE is $150M as of March 2026. That compares with $9.9M in the prior-year period — up 1442.2% year over year. Investors often review this figure alongside Sensei Biotherapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, SNSE's current cash moved from $9.9M to $150M — a 1442.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sensei Biotherapeutics's operating scale or balance-sheet position.

A current cash figure of $150M for SNSE is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SNSE's current cash ($150M), review year-over-year change from $9.9M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Sensei Biotherapeutics's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.